Latest Clinical Data Highlights Efficacy of Smith & Nephew's Advanced Wound Care Product Portfolio

ST. PETERSBURG, Fla., April 19 /PRNewswire/ -- The Advanced Wound Management division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc (LSE: SN) (NYSE: SNN) announced today that a total of 16 posters on studies conducted with its advanced wound care products were presented at this year's Symposium on Advanced Wound Care (SAWC) and Wound Healing Society (WHS) meeting.  Posters presented included recent clinical data on studies conducted using RENASYS™ Negative Pressure Wound Therapy (NPWT) technology, ACTICOAT™ Silver-coated antimicrobial barrier dressings, ALLEVYN™, ALLEVYN Ag and IODOSORB™ Cadexomer Iodine wound dressings. They can be viewed Monday, April 19 from 7:30 AM until 6:00 PM.

Smith & Nephew is highlighting its full portfolio of advanced wound care products at booth 301.

"We have been looking forward to showing the latest clinical results achieved with the full range of Smith & Nephew's advanced wound management products," said Tom Dugan, North American President of Advanced Wound Management at Smith & Nephew. "We are building a substantial body of clinical evidence around the efficacy of our RENASYS NPWT systems and presented the results from our first prospective, non-comparative study on the efficacy of the RENASYS - F™ Foam Dressings at this year's SAWC/WHS conference."

The clinical data on display at SAWC/WHS underscore the innovative range of products from Smith & Nephew, and demonstrate the company's ability to offer flexibility of choice to clinicians in achieving clinical and cost effectiveness in the management of acute and chronic wounds. Highlights of the data include the following posters:

• A Prospective Multi-Centre Clinical Evaluation of Gauze-Based NPWT: Results from 131 Patients – Dr. Raymond M. Dunn, Plastic Surgeon, University of Massachusetts Medical Center, Worcester, MA; Ron Ignotz, PhD; Heather Strom, BS; Theresa Hurd, RN, MScN, MSN, Med, ACNP; Julien Cote, RN; Vicki Vasquez, RN, CWS, CHRN; John Cockwill, MS, CCRP; Trevor Mole, PhD; Jenny Smith, PhD
• Clinical Efficacy of an Alternative Foam-based NPWT System in the Middle East – Dr. Samer Bondogke, DPM, International Medical Centre, Jeddah; Dr. Chris Reuter, Head of Surgical Department, Mafraq Hospital, Abu Dhabi; Dr. Mohan Rangaswamy, Plastic Surgeon, Welcare Hospital, Dubai, UAE; Dr. Marwan Ahmad Al Zarouni, Plastic Surgeon, Rashid Hospital, Dubai, UAE; Sister Maggie Lavidaris, Wound Care Specialist, Dubai Hospital, Dubai, UAE; Jenny Smith, PhD; Trevor Mole, PhD; John Cockwill, MS, CCRP, Smith & Nephew Wound Management, St. Petersburg, FL
• A Prospective, Open, Multi-centre Study to Evaluate the Functionality and Device Performance of RENASYS GO™ in the Management of Acute and Chronic Wounds in South Africa – Professor Don Hudson; Dr. Kevin Adams
• A Prospective, Non-comparative, Clinical Evaluation to Determine the Effect of ALLEVYN/ALLEVYN Ag™ on the reduction of Bioburden and Closure of Venous Leg Ulcers – Dr. John C. Lantis; Cindy Gendics, RN, CCRA

About SAWC/WHS

The 23rd Annual SAWC/WHS Spring Meeting is the largest gathering of multidisciplinary wound care clinicians in the United States. The meeting opened on Saturday, April 17th and concludes Tuesday, April 20th at the Gaylord Palms Hotel in Orlando, Florida. For more information, visit http://spring.sawc.net/legacy/spring09.html.

For more information about Smith & Nephew, please go to www.smith-nephew.com.  Product-specific information is available at www.myrenasys.com, www.versajet.info, www.allevyn.com, www.iodosorb.com, www.acticoat.com.

About Us

Smith & Nephew is a global medical technology business, specialising in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies; Endoscopy and Advanced Wound Management.  Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.

Smith & Nephew is dedicated to helping improve people's lives.  The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust.  The Company operates in 32 countries around the world.  Annual sales in 2009 were nearly $3.8 billion.

Forward-Looking Statements

This press release contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995.  In particular, statements regarding expected revenue growth and trading margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline.  These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements.  Such forward-looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation, claims and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements.  Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.

All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof.  All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing.  Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew's expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

™Trademark of Smith & Nephew. Certain marks Reg. US Pat. & TM Office.

SOURCE Smith & Nephew, Inc.